Rentokil Stock Plummets. The U.S. Pest Control Market Is a Big Worry. -- Barrons.com

Dow Jones
2024-09-11

By George Glover

Investors are starting to wonder which sectors will suffer if the U.S. economy flatlines. Add pest control to the worry list.

Terminix owner Rentokil Initial said in a trading update that it would cut its fiscal 2024 sales outlook on Monday, flagging weakness over the past two months in the key North American market. It's now expecting second-half revenue growth of just 1% in the region, another revision downward after it slashed its guidance to growth of between 2% and 4% back in July.

Rentokil is based in Crawley in the U.K., and is listed in both London and New York. U.K. shares plunged 18% to 390 pounds ($511) on Wednesday, while its American depositary receipts cratered 17% to $26.10 ahead of the opening bell. As of Tuesday's close, the ADRs had fallen 12% for the year.

The pest-control giant also lowered its North American profit guidance by 20 million pounds ($26.2 billion), adding that it would aim to cut costs by managing its inventory, tweaking technician workload, and overtime, and adjusting its labor resource to reflect lower volume of demand.

Activist investor Nelson Peltz is one of Rentokil's 10 largest shareholders, with his firm Trian Partners revealing a "significant" stake in the company in June as it bids to turn the page on its defeat in a bruising proxy battle at Walt Disney.

Shares in fellow pest-control company Rollins tumbled 5.4% in premarket trading. Futures for the benchmark S&P 500 declined 0.3%.

Write to George Glover at george.glover@dowjones.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

September 11, 2024 06:27 ET (10:27 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10